CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

Weather - Berlin 29°C

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets

ECONOMY 08.09.2026

CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets / Photo: © Financewire ( 212726 )

CapTLX, the securities trading and investment platform operated by CHAINLION TECH LTD, today announced the continued expansion of its technology infrastructure for qualified investors and institutional market participants seeking structured access to U.S. equity and private capital markets.

Change text size:

Established on August 12, 2021, CHAINLION TECH LTD operates CapTLX with a focus on developing institutional-oriented infrastructure supporting participation in private and primary capital markets. Through the CapTLX platform, the company is developing capabilities designed to support U.S. equity trading accounts, investment management services, and a range of capital-market transactions.

CapTLX is designed to support qualified investors and institutional-oriented participants across activities including IPO participation, corporate financing, private equity, block trading, quantitative investment strategies, and equity-backed financing. The platform brings these capabilities together through technology infrastructure intended to support structured access to U.S. securities and capital-market opportunities.

The development of CapTLX reflects growing international demand for efficient connectivity to U.S. capital markets and structured investment solutions. In its early stages, the platform focused on investors and market participants across Asia and Europe. Its operating framework has since continued to develop with an international focus, supporting connectivity across additional financial and commercial markets.

CapTLX's platform is designed around technology-driven infrastructure, market intelligence, transaction-support capabilities, and structured investment frameworks. The objective is to provide qualified investors with an organized environment through which they can evaluate and pursue selected opportunities within the U.S. equity and private-market ecosystem.

The platform's capabilities span a broad range of institutional-oriented activities, including IPO participation, dark pool trading, corporate financing solutions, private equity investments, block trading, quantitative trading strategies, and equity-pledge and securities-backed financing.

By bringing multiple capital-market functions together, CapTLX aims to support sophisticated investment and financing requirements while providing a technology-enabled environment for transaction execution and capital deployment.

CapTLX has also developed an international operating network spanning financial and commercial centers including the United States, Canada, Hong Kong, Indonesia, London, Dallas, Singapore, Oman, Kuala Lumpur, Uganda, and Zambia, among other markets.

This geographically diversified framework is designed to support cross-border operations, localized client services, and connectivity between international investors and capital markets. The company intends to continue developing its international infrastructure as part of its broader strategy for serving qualified investors across multiple regions.

As capital markets become increasingly technology-driven and internationally connected, CapTLX is focused on building an integrated platform that combines market access, investment infrastructure, transaction support, and risk-management processes.

The company's long-term objective is to develop a comprehensive U.S. equity investment platform that combines institutional-oriented technology, structured investment solutions, and disciplined risk-management frameworks. Through continued investment in technology, operational infrastructure, market connectivity, and risk-management capabilities, CapTLX aims to strengthen its position within the evolving global capital-markets ecosystem.

About CapTLX

CapTLX is an institutional-oriented securities trading and investment platform operated by CHAINLION TECH LTD. The platform is focused on providing qualified investors and institutional market participants with structured access to selected U.S. equity, private-market, and primary-market opportunities.

CapTLX integrates technology infrastructure, market intelligence, investment frameworks, transaction-support capabilities, and financing solutions within a unified platform. Its capabilities are designed to support activities including IPO participation, private equity, block trading, quantitative investment strategies, corporate financing, and securities-backed financing.

With an international operating focus, CapTLX is developing its platform and connectivity across multiple financial markets while pursuing its long-term objective of building a comprehensive technology-enabled ecosystem for U.S. capital-market participation.

About CHAINLION TECH LTD

CHAINLION TECH LTD is the operating company behind CapTLX, with a focus on developing technology-enabled infrastructure and investment solutions for qualified investors and institutional market participants.

Through CapTLX, the company seeks to provide structured access to U.S. equity and private-market opportunities while integrating investment services, market intelligence, technology infrastructure, and transaction-support capabilities within a unified platform.

Contact

CHAINLION TECH LTD
[email protected]

Source article: https://financewire.com/2026/09/08/captlx-expands-institutional-oriented-platform-for-access-to-u-s-capital-markets/

(P.Tomczyk--DTZ)

Featured

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Deutsche Tageszeitung - CapTLX Expands Institutional-Oriented Platform for Access to U.S. Capital Markets